Kahler Thomas Clay 4
4 · Tharimmune, Inc. · Filed Nov 5, 2025
Insider Transaction Report
Form 4
Tharimmune, Inc.THAR
Kahler Thomas Clay
Director
Transactions
- Award
Stock Option
2025-11-03+17,500→ 67,500 totalExercise: $3.08From: 2025-11-03Exp: 2035-11-03→ Common Stock (17,500 underlying)